{
  "id": "d872f7aa35bd64db",
  "title": "Granules gets USFDA nod for generic ADHD drug - The HinduBusinessLine",
  "description": "20260108T094500Z",
  "content": "",
  "source": "thehindubusinessline.com",
  "source_url": "https://www.thehindubusinessline.com/companies/granules-gets-usfda-nod-for-generic-adhd-drug/article70485161.ece",
  "published_at": "20260108T094500Z",
  "fetched_at": "2026-01-09T00:23:18.491015+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda",
    "drug"
  ],
  "location": "India",
  "raw_data": {
    "url": "https://www.thehindubusinessline.com/companies/granules-gets-usfda-nod-for-generic-adhd-drug/article70485161.ece",
    "url_mobile": "https://www.thehindubusinessline.com/companies/granules-gets-usfda-nod-for-generic-adhd-drug/article70485161.ece/amp/",
    "title": "Granules gets USFDA nod for generic ADHD drug - The HinduBusinessLine",
    "seendate": "20260108T094500Z",
    "socialimage": "https://bl-i.thgim.com/public/incoming/a7vk2s/article70357178.ece/alternates/LANDSCAPE_1200/Granules%20India.jpg",
    "domain": "thehindubusinessline.com",
    "language": "English",
    "sourcecountry": "India"
  }
}